High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia.
Wen DuJing HeWei ZhouSimin ShuJuan LiWei LiuYun DengCong LuShengyan LinYaokun MaYanli HeJine ZhengJiang ZhuLijuan BaiXiaoqing LiJunxia YaoDan HuShengqing GuHuiyu LiAnyuan GuoShiang HuangXiaolan FengDong HuPublished in: Journal of translational medicine (2019)
High IL2RA mRNA expression is an independent and adverse prognostic factor in AML and specifically stratifies patients to worse prognosis in both CBF and intermediate-risk AML.
Keyphrases
- acute myeloid leukemia
- prognostic factors
- end stage renal disease
- rheumatoid arthritis
- allogeneic hematopoietic stem cell transplantation
- ejection fraction
- chronic kidney disease
- disease activity
- peritoneal dialysis
- systemic lupus erythematosus
- patient reported outcomes
- adverse drug
- binding protein
- patient reported